Gastroenteritis Testing Market Research Reveals Strong 5.8% CAGR Outlook Through 2030

The gastroenteritis testing market is on track for notable expansion as advancements in diagnostic technologies continue to emerge. With increasing demand for quick, accurate testing and broader disease surveillance, this sector is positioned for steady growth in the coming years. Let's explore the market size projections, key industry players, innovative trends, and detailed segment analysis shaping the future of gastroenteritis diagnostics.

Projected Growth and Market Size of the Gastroenteritis Testing Market
The global gastroenteritis testing market is forecasted to reach a value of $5.55 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.8%. This upward trajectory is fueled by progress in molecular diagnostic technologies, a rising preference for rapid point-of-care testing solutions, increased investment in infectious disease research, wider adoption of integrated laboratory information systems, and the expansion of gastroenteritis testing services in emerging economies. Key trends influencing this growth include heightened demand for fast and precise diagnostics, growing use of molecular testing methods, broadening test panels that cover viral, bacterial, and parasitic infections, the rising role of hospital and point-of-care testing, and an intensified focus on epidemiological monitoring and management of outbreaks.

Download a free sample of the gastroenteritis testing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20556&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Primary Players Leading the Gastroenteritis Testing Market
Several well-established companies are prominent within the gastroenteritis testing sector. These major players include F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Abbott Diagnostics, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Eurofins Scientific SE, Hologic Inc., Becton dic*kinson and Company, bioMérieux SA, Quest Diagnostics Incorporated, DiaSorin S.p.A., Bio-Rad Laboratories Inc., Randox Laboratories Ltd., ARUP Laboratories, Meridian Bioscience Inc., MedGenome, Trinity Biotech plc, Savyon Diagnostics Ltd., Coris BioConcept, Aster Clinical Research & Diagnostic Centre Pvt. Ltd., Alimetrix Inc., and Luminex Corporation.

Strategic Partnership to Broaden Diagnostic Reach
In December 2024, the Indian Council of Medical Research (ICMR), a leading national medical research body in India, formed a partnership with Molbio Diagnostics Pvt. Ltd. This collaboration aims to extend the global availability of Molbio's advanced multiplex RT-PCR technology, which detects enteric viruses responsible for childhood gastroenteritis. By leveraging Molbio's expertise in commercialization and its worldwide diagnostic distribution network, this initiative seeks to improve timely and accurate disease detection. Molbio Diagnostics is known for providing portable and rapid molecular diagnostic solutions tailored to diverse healthcare environments.

View the full gastroenteritis testing market report:
https://www.thebusinessresearchcompany.com/report/gastroenteritis-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Innovations and Market Opportunities in Gastroenteritis Testing
Key industry players are innovating with molecular gastrointestinal tests that offer high sensitivity and specificity for detecting pathogens. Molecular testing uses techniques like polymerase chain reaction (PCR) to identify genetic material from viruses, bacteria, or parasites in gastrointestinal samples. For example, in June 2024, Germany-based QIAGEN N.V. introduced the QIAstat-Dx Gastrointestinal Panel 2. This test stands out by rapidly identifying up to 16 clinically relevant bacterial, viral, and parasitic pathogens responsible for common gastrointestinal infections. Its real-time PCR technology allows simultaneous amplification of multiple genetic targets in one run, significantly reducing the time required compared to conventional methods that often take from 24 hours up to 10 days.

Detailed Segmentation of the Gastroenteritis Testing Market
This market is segmented into various categories to provide comprehensive insights:
1) By Type of Infection: Viral Gastrointestinal Infections, Bacterial Gastrointestinal Infections, and Parasitic Gastrointestinal Infections.
2) By Disease Strains: Specific bacterial, viral, and parasitic strains responsible for infections.
3) By Testing Methodology: Immunoassay Testing, Conventional Testing, and Molecular Diagnostic Testing.
4) By End-User: Hospitals, Clinics or Medical Centers, Research Institutes, and Diagnostic Laboratories.

Further breakdown includes:
- Viral Gastrointestinal Infections such as Norovirus, Rotavirus, Astrovirus, Adenovirus, and Sapovirus.
- Bacterial Gastrointestinal Infections including Escherichia coli (E. coli), Salmonella, Campylobacter, Shigella, and Clostridium perfringens.
- Parasitic Gastrointestinal Infections like Giardia lamblia, Entamoeba histolytica, Cryptosporidium, Trichinella, and Strongyloides stercoralis.

This thorough segmentation highlights the scope and depth of the gastroenteritis testing market, helping stakeholders understand targeted areas for development and investment.

Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.